The Effectiveness and Change Mechanisms of Mentalization Based Therapy for Children (MBT-C)
1 other identifier
interventional
222
1 country
1
Brief Summary
The main aim of the project is to investigate the effectiveness and change mechanisms of Mentalization Based Therapy for Children (MBT-C; Midgley et al., 2017). MBT-C is a transdiagnostic treatment for children aged between 5 to 12 years old with the main aim of increasing mentalization and restoring epistemic trust. Parallel parental work takes place to increase parental mentalization. This project will test the effectiveness of MBT-C in a parallel group single blind pragmatic Randomized Controlled Trial (pRCT) conducted in Turkey in comparison to a parenting and social skills group. The sample will include 240 children between 5-12 years old with internalizing and externalizing and comorbid internalizing/externalizing problems and their parents. During the study, the patients will be randomized to two arms, and the treatment's effectiveness will be investigated both at short (8th and 12th weeks) and long terms (24th and 36th week) to also assess relapse prevention. Thelarge sample size and the longitudinal evaluation of primary (decrease in problems), and secondary outcomes will enable the investigation of mediators and moderators. This project will also undertake a rigorous psychotherapy process study within the RCT, examining for the first time, for which children and under what circumstances MBT-C may be most effective, meaningfully linking process with outcome. For this purpose, patients' baseline characteristics, especially attachment security and mentalization deficits that may interact with treatment outcome (moderators) and different dimensions of mentalization that develop over the course of the treatment (change mechanisms/mediators) will be assessed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 26, 2022
CompletedStudy Start
First participant enrolled
March 15, 2022
CompletedFirst Posted
Study publicly available on registry
March 22, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2025
CompletedMay 1, 2025
April 1, 2025
1.8 years
February 26, 2022
April 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from Baseline to 36th week on the Child Behavior Checklist (CBCL)
The Child Behavior Checklist (CBCL; Achenbach, 1991) is a widely used method of identifying problematic behaviors in children with two separate versions for ages 1.5-5 and 6-18. The CBCL asks the parents to indicate how true a series of 112 problem behavior items are for their child in the past two months on a 3-point likert scale (0 = "not true", 1= "sometimes true", and 2 = "very true or often true"). Outcomes can be determined for significant problems for Internalizing (e.g., depression, anxiety), Externalizing (e.g., aggression, violence) or Total Problems. The scale has been adapted to Turkish with good reliability and validity (Erol et al., 1995).
Baseline (T0), 8th week (T1), 12th week (T2), 24th week (T3), 36th week (T4)
Secondary Outcomes (6)
Change from Baseline to 36th week on the Me and My Feelings Questionnaire (M&MF)
Baseline (T0), 8th week (T1), 12th week (T2), 24th week (T3), 36th week (T4)
Change from Baseline to 36th week on the Emotion Regulation Checklist (ERC)
Baseline (T0), 8th week (T1), 12th week (T2), 24th week (T3), 36th week (T4)
Change from Baseline to 12th week on the Children's Global Assessment Scale (CGAS)
Baseline (T0), 8th week (T1), 12th week (T2)
Change from Baseline to 36th week on the Parental Stress Index - Short Form (PSI-SF)
Baseline (T0), 8th week (T1), 12th week (T2), 24th week (T3), 36th week (T4)
Change from Baseline to 36th week on the Parent Reflective Functioning Questionnaire (PRF-Q)
Baseline (T0), 8th week (T1), 12th week (T2), 24th week (T3), 36th week (T4)
- +1 more secondary outcomes
Other Outcomes (11)
Screening: Brief Symptom Inventory (BSI)
Baseline (T0)
Screening: Schedule for Affective Disorders and Schizophrenia for School Aged Children (6-18 Years) (K-SADS-PL DSM-5)
Baseline (T0)
Screening: Kaufman Brief Intelligence Test-Second Edition (KBIT-2)
Baseline (T0)
- +8 more other outcomes
Study Arms (2)
Mentalization Based Treatment for Children (MBT-C)
EXPERIMENTALMentalization Based Therapy for Children (MBT-C) is a transdiagnostic time-limited (12 weekly sessions) and manualized treatment for children aged between 5 to 12 years old with the main aim of increasing mentalization and restoring epistemic trust. Parallel parental work takes place to increase parental mentalization.
Parenting and Social Skills Group
ACTIVE COMPARATORParenting groups will run for 12 weeks with 10 parents per group. They will involve activities to help parents develop effective parenting skills via working on a family genogram, providing information on child development, developing acceptance and empathy, setting boundaries and anger regulation. The social skills groups will run for 12 weeks and will be conducted with 10 children per group. They will involve activities on self-presentation, peer communication, play skills, empathy and anger management.
Interventions
MBT-C will involve 12 paralel individual sessions with the parents and children separately conducted by two different therapists.
Parenting/social skills groups will be co-led by two therapists and involve 12 group therapy sessions with the parents and their children separately (10 parents and children per group).
Eligibility Criteria
You may qualify if:
- Child age 5 to 12 years old
- Clinical levels of child internalizing, externalizing and comorbid internalizing/externalizing problems (clinical levels on CBCL)
You may not qualify if:
- a clinical diagnosis of autistic spectrum disorders (ASD) (meets KSADS-PL threshold criteria)
- severe intellectual impairment (below 5th percentile on KBIT-2)
- a clinical diagnosis of psychosis (meets KSADS-PL threshold criteria)
- severe conduct disorder (clinical range on CBCL DSM-Oriented Conduct Problems scale)
- severe substance abuse and dependence (meets KSADS-PL threshold criteria)
- acute risk of harm to self and others (KSADS-PL risk item scores = 3)
- an emergency/crisis referral, where an immediate response to a significant risk is required
- Parents
- risk of psychotism (clinical on BSI psychotism scale)
- severe intellectual impairment (below 5th percentile on KBIT-2)
- severe substance abuse and dependence (positive case on BAPIRIT)
- acute risk of harm to self and others (BSI item 9, 39 \& 40 = 4)
- an emergency/crisis referral, where an immediate response to a significant risk is required
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istanbul Bilgi University Psychological Counseling Center
Istanbul, Istanbul, 34060, Turkey (Türkiye)
Related Publications (1)
Midgley, N., Ensink, K., Lindqvist, K., Malberg, N., & Muller, N. (2017). Mentalization-based treatment for children: A time-limited approach. American Psychological Association. https://doi.org/10.1037/0000028-000
BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
SİBEL HALFON, PhD
Istanbul Bilgi University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
February 26, 2022
First Posted
March 22, 2022
Study Start
March 15, 2022
Primary Completion
January 1, 2024
Study Completion
February 1, 2025
Last Updated
May 1, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- At the end of the study
After publication of the primary objective, published data might be provided to interested scientists on request for meta-analyses or secondary analyses of variables of interest in an anonymized way, with permission from the trial team.